欢迎来到天天文库
浏览记录
ID:44290610
大小:1.39 MB
页数:44页
时间:2019-10-20
《上海CMC培训 Ensuring Drug Quality for Public Health The Implementation》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、1EnsuringDrugQualityforPublicHealthTheImplementationBrendaUratani,Ph.D.AssistantCountryDirectorFDAChinaOffice,Beijing2OverviewChallengestoGlobalizationofDrugManufacturingFDA’sWorkinChinaGMPPrinciples:Issuesofthemostconcern3ChallengesSignificantdemandin
2、resourcesforinspectionsConsequencesofglobalization,includingmoreforeignmanufacturingandclinicaltrialssitesGreatercomplexityassociatedwithmanufacturingFDAconcernaboutthestateofindustrycomplianceandinsufficientinvestmentinmanufacturingandqualitysystems4F
3、DAInternationalEffortsFDAOverseasEffortsLong-TermGoalProductscomingtotheU.S.meetU.S.requirements.StrengthenedRegulatoryCounterpartsIndustryResponsibility:SupplyChainManagementatPointofManufacture,PointofExport,andWhenPresentedforImportation5FDAOversea
4、sPresenceCurrentLocationsChinaIndiaLatinAmericaEuropeMiddleEast(2010)6FDA’sWorkinChina78FDAChinaOfficeIn-CountryStaffBeijingChrisHickey,OfficeDirectorMikeKravchuk,Deputy(device)BrendaUratani(drug)IreneChan(food)ShanghaiCharlesAhn(druginspection)BJMarc
5、iante(deviceinspection)GuangzhouDennisDoupnik(foodinspection)DennisHudson(foodinspection)FDA/SFDAAgreement:KeyProvisionsKeyProvisions:RegistrationofdesignateddrugsanddevicesJointTraining/CapacityBuildingGreater/MoreRapidInformationSharingGreaterAccesst
6、oFacilitiesProductIntegrity/Anti-counterfeitingStrengthenedFDA,SFDACollaborationUnderMultilateralAuspices9DrugsinChina:WhatHasFDADone?FDA-SFDACollaborationInspectionsEngagementofIndustryCapacity-Building10WhatIsChinaDoing?UpdatingStandards,MethodsRevis
7、ionofChinaCGMPWorkingtoImproveDrugAdverseEventReportingTrainingEliteGroupofInspectorsRe:InternationalStandardsAttemptingtoStrengthenDrugApplicationReviewProcessTakingMoreActiveRoleinInternationalStandard-SettingShiftingFocustoConductMorePre-ApprovalIns
8、pectionsUtilizingToolstoDetectCounterfeitingSupplyChain:DevelopingToolsandStandardsforTracking/Tracing11China’sRoleinDrugDevelopment:ChallengesforChinaNeedforRegulatoryReformUniformityofimplementationofCGMPacrossallprovincesRegulatoryAu
此文档下载收益归作者所有